{"type":"rich","html":"<script src=\"http:\/\/leconomic.cat\/media\/epa\/iframeresizer\/iframeResizer.min.js\"><\/script><iframe class=\"epa-embed\" src=\"http:\/\/leconomic.cat\/article\/1786005-desenvolupament-de-farmacs-contra-la-covid-19.html?utm_medium=oembed&amp;utm_source=desconegut&amp;utm_campaign=oembed&amp;layout=oembed&amp;tmpl=oembed\" height=\"auto\" frameborder=\"0\" style=\"border: 0px; margin: 1px; min-height: 200px;  max-width: 658px; width: calc(100% - 2px); display: block; padding: 0px; background: rgb(255, 255, 255);\"><\/iframe><script>iFrameResize({log:false, checkOrigin: ['http:\/\/leconomic.cat']})<\/script>","version":"1.0","provider_name":"El Punt Avui","provider_url":"http:\/\/www.elpuntavui.cat","resource_url":"http:\/\/leconomic.cat\/article\/1786005-desenvolupament-de-farmacs-contra-la-covid-19.html?utm_medium=oembed&amp;utm_source=desconegut&amp;utm_campaign=oembed","title":"Desenvolupament de f\u00e0rmacs contra la covid-19","description":"En les darreres setmanes, s\u2019han iniciat en l\u2019\u00e0mbit internacional m\u00e9s de 300 estudis cl\u00ednics contra la covid-19. En el costat positiu, \u00e9s important que hi hagi diversificaci\u00f3 d\u2019estrat\u00e8gies per...","author_name":"Maribel Berges","author_url":"http:\/\/leconomic.cat\/e-opinio\/autor\/mberges.html?app_id=100","thumbnail_url":"https:\/\/www.elpuntavui.cat\/imatges\/59\/33\/baixa\/780_0008_5933555_fe732a62a036c51d8187d0509db8f3b3.jpg","thumbnail_width":"224","thumbnail_height":"150","width":"100","height":"100"}